Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PMP22 | Q01453 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | DPP4 | P27487 | 2/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.45 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28313344 | 0.90 | ALOX15 (0.60) | PMP22ALOX15BLMKMT2ADPP4 | |
| SCHEMBL711607 | 0.90 | ALOX15 (0.60) | PMP22ALOX15BLMKMT2ADPP4 | |
| SCHEMBL508161 | 0.87 | ALOX15 (0.48) | PMP22ALOX15BLMKMT2ADPP4 | |
| SCHEMBL1537454 | 0.85 | ALOX15 (0.47) | PMP22ALOX15BLMKMT2ADPP4 | |
| SCHEMBL12497981 | 0.85 | ALOX15 (0.47) | PMP22ALOX15BLMKMT2ADPP4 | |
| SCHEMBL2695665 | 0.85 | ALOX15 (0.47) | PMP22ALOX15BLMKMT2ADPP4 | |
| SCHEMBL1537291 | 0.85 | ALOX15 (0.47) | PMP22ALOX15BLMKMT2ADPP4 | |
| SCHEMBL8637362 | 0.85 | SLC1A1 (0.35) | PMP22ALOX15BLMKMT2ADPP4 | |
| SCHEMBL1988217 | 0.85 | SLC1A1 (0.35) | PMP22ALOX15BLMKMT2ADPP4 | |
| SCHEMBL3402553 | 0.85 | GABRP (0.52) | PMP22ALOX15BLMKMT2ADPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3564376-B1 | GENE ENCODING ALANYL-GLUTAMINE DIPEPTIDE BIOSYNTHETIC ENZYME AND APPLICATION THEREOF | INNOBIO CORPORATION LTD (CN) | 2021-12-15 | — | — | EP | claimed |
| EP-3880167-A1 | METHOD OF PRESERVING CELLS FOR THERAPEUTIC USE | Laboratoire Français du Fractionnement et des Biotechnologies (FR) | 2021-09-22 | — | — | EP | claimed |
| EP-3716762-A1 | METHOD FOR THE CRYOPRESERVATION OF CELLS FOR THERAPEUTIC PURPOSES | Laboratoire Français du Fractionnement et des Biotechnologies (FR) | 2020-10-07 | — | — | EP | claimed |
| WO-2020099571-A1 | METHOD OF PRESERVING CELLS FOR THERAPEUTIC USE | LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES (FR) | 2020-05-22 | — | — | WO | claimed |
| US-10557854-B2 | CA IX—NIR dyes and their uses | On Target Laboratories, LLC (US) | 2020-02-11 | — | — | US | claimed |
| WO-2019102172-A1 | METHOD FOR THE CRYOPRESERVATION OF CELLS FOR THERAPEUTIC PURPOSES | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES (FR) | 2019-05-31 | — | — | WO | claimed |
| EP-3148563-B1 | METHODS AND COMPOSITIONS FOR ENHANCEMENT OF ABILITY TO CONCENTRATE | KYOWA HAKKO BIO CO LTD (JP) | 2019-05-22 | — | — | EP | claimed |
| EP-2819685-B1 | Use of alanylglutamine for enhancing vision performance | KYOWA HAKKO BIO CO LTD (JP) | 2018-04-18 | — | — | EP | claimed |
| EP-2496232-B1 | A METHOD TO ENHANCE ENDURANCE | KYOWA HAKKO BIO CO LTD (JP) | 2016-08-31 | — | — | EP | claimed |
| EP-2129370-B1 | Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue | ZYTOPROTEC GMBH (AT) | 2012-11-21 | — | — | EP | claimed |
| EP-1663283-B1 | GLUTAMINE FOR USE IN TREATING INJURY | UNIV COLORADO (US) | 2012-05-23 | — | — | EP | claimed |
| EP-1940439-B1 | REDUCING POST-OPERATIVE ADHESION FORMATION WITH INTRAPERITONEAL GLUTAMINE | UNIV SASKATCHEWAN (CA) | 2010-10-27 | — | — | EP | claimed |
| EP-0906333-B1 | SUBSTRATES AND INHIBITORS OF PROTEOLYTIC ENZYMES | MEDIVIR UK LTD (GB) | 2001-07-25 | — | — | EP | claimed |
| EP-0595345-B1 | Process for producing alanylglutamine | KYOWA HAKKO KOGYO KK (JP) | 2000-01-12 | — | — | EP | claimed |
| US-11987633-B2 | Cross-species-specific single domain bispecific single chain antibody | AMGEN RESEARCH (MUNICH) GMBH (DE) | 2024-05-21 | — | — | US | disclosed |
| CN-114345825-B | Mask cleaning method, cleaning liquid, cleaning apparatus, and method for manufacturing organic device | 大日本印刷株式会社 | 2023-08-22 | — | — | CN | disclosed |
| EP-4180458-A1 | CROSS-SPECIES-SPECIFIC PSMA X CD3 BISPECIFIC SINGLE CHAIN ANTIBODY | Amgen Research (Munich) GmbH (DE) | 2023-05-17 | — | — | EP | disclosed |
| EP-1437966-A1 | MEASUREMENT OF PROTEIN SYNTHESIS RATES IN HUMANS AND EXPERIMENTAL SYSTEMS BY USE OF ISOTOPICALLY LABELED WATER | The Regents of the University of California (US) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003061479-A1 | MEASUREMENT OF PROTEIN SYNTHESIS RATES IN HUMANS AND EXPERIMENTAL SYSTEMS BY USE OF ISOTOPICALLY LABELED WATER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-07-31 | — | — | WO | disclosed |
| WO-2000059925-A1 | A PROCESS FOR THE PRODUCTION OF GLUTAMINE DERIVATIVES AND GLUTAMINE CONTAINING MOLECULES | THE UNIVERSITY OF VIRGINIA (US) | 2000-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10557854-B2 | CA IX—NIR dyes and their uses | CA9, CA13, CA4 | PMP22 4778/4885ALOX15 1706/4885BLM 4551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.